Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The study aims to collect data on the influence of a treatment with Visanne (Dienogest 2mg/d)
on the Endometriosis related quality of life. These data will be collected using a special
patient questionnaire (Endometriosis Health Profile 5, EHP-5). The study will also be used to
describe the basic disease status and demographic characteristics of patients searching
treatment by a gynecologist because of their endometriosis. In addition, the study will give
insight into the typical diagnostic measures the physicians in different countries are using
in the field of endometriosis.